Related Experiment Video
Updated: Jul 19, 2026

Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Extrachromosomal Circular DNA as a Cancer Biomarker: From Diagnosis to Treatment
Hexin Li1, Jiahui Cai1, Gang Zhao2,3
1Clinical Biobank, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China.
Abstract:
Extrachromosomal circular DNA (eccDNA) is an emerging class of genetic material that exists outside of the chromosomal genome. These circular DNA molecules are gaining increasing attention as important biomarkers in various cancers because of their roles in gene amplification, genetic heterogeneity, and drug resistance. In this review, we explore in depth the impacts of eccDNAs on cancer biology, their potential to predict treatment sensitivity and resistance, and their involvement in the development of new anticancer therapies. eccDNAs can be used as biomarkers for various tumor types to help diagnose and predict prognosis.
Insights
Extrachromosomal circular DNA (eccDNA) shows promise as cancer biomarkers. These genetic elements impact cancer biology, treatment resistance, and therapeutic development, aiding diagnosis and prognosis.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Extrachromosomal circular DNA (eccDNA) represents genetic material outside the main genome.
- eccDNA's role in gene amplification, heterogeneity, and drug resistance is increasingly recognized in cancer.
Purpose of the Study:
- To review the impact of eccDNA on cancer biology.
- To explore eccDNA's potential in predicting treatment sensitivity and resistance.
- To discuss eccDNA's role in developing novel anticancer therapies.
Main Methods:
- Literature review of eccDNA research in cancer biology.
- Analysis of eccDNA's functions in gene amplification and drug resistance.
- Evaluation of eccDNA as a diagnostic and prognostic biomarker.
Main Results:
- eccDNA significantly influences cancer development and progression.
- eccDNA levels correlate with treatment sensitivity and resistance.
- eccDNA serves as a valuable biomarker for cancer diagnosis and prognosis.
Conclusions:
- eccDNA is a critical factor in cancer biology with significant therapeutic implications.
- Further research into eccDNA can lead to improved cancer diagnostics and treatments.
- eccDNA holds potential as a versatile biomarker for various tumor types.
Related Concept Videos
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

